Stifel Financial’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-153
Closed -$57K 3116
2020
Q3
$57K Sell
153
-366
-71% -$162K ﹤0.01% 2802
2020
Q2
$255K Hold
519
﹤0.01% 2460
2020
Q1
$191K Hold
519
﹤0.01% 2453
2019
Q4
$367K Hold
519
﹤0.01% 2437
2019
Q3
$333K Hold
519
﹤0.01% 2392
2019
Q2
$453K Hold
519
﹤0.01% 2267
2019
Q1
$300K Sell
519
-1
-0.2% -$418 ﹤0.01% 2361
2018
Q4
$145K Sell
520
-11
-2% -$4.35K ﹤0.01% 2514
2018
Q3
$255K Buy
531
+146
+38% +$62.6K ﹤0.01% 2454
2018
Q2
$173K Hold
385
﹤0.01% 2578
2018
Q1
$226K Buy
385
+12
+3% +$7.48K ﹤0.01% 2408
2017
Q4
$231K Sell
373
-1
-0.3% -$718 ﹤0.01% 2355
2017
Q3
$345K Sell
374
-2
-0.5% -$1.78K ﹤0.01% 2092
2017
Q2
$351K Sell
376
-1
-0.3% -$980 ﹤0.01% 2051
2017
Q1
$359K Sell
377
-5
-1% -$4.66K ﹤0.01% 1999
2016
Q4
$305K Sell
382
-2
-0.5% -$1.8K ﹤0.01% 2032
2016
Q3
$324K Sell
384
-16
-4% -$12.9K ﹤0.01% 1945
2016
Q2
$329K Buy
400
+12
+3% +$13.1K ﹤0.01% 1994
2016
Q1
$431K Sell
388
-1
-0.3% -$1.02K ﹤0.01% 1659
2015
Q4
$486K Sell
389
-23
-6% -$38K ﹤0.01% 1682
2015
Q3
$556K Sell
412
-5
-1% -$8.25K ﹤0.01% 1492
2015
Q2
$749K Buy
417
+41
+11% +$63.6K ﹤0.01% 1481
2015
Q1
$608K Buy
376
+4
+1% +$5.93K ﹤0.01% 1522
2014
Q4
$283K Buy
+372
New +$197K ﹤0.01% 1907

Other funds holding TCRT

Stifel Financial's TCRT Position: Q4 2020 in Review

Stifel Financial sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 153 shares — an estimated $57K sold.

Stifel Financial first reported a position in TCRT in Q4 2014 and held it in 24 quarters. The position peaked at $749K in Q2 2015. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • Stifel Financial reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Stifel Financial sold 153 Alaunos Therapeutics shares in Q4 2020, an estimated $57K.
  • Stifel Financial first reported a position in Alaunos Therapeutics in Q4 2014 and held it in 24 quarters.
  • Stifel Financial's Alaunos Therapeutics position peaked at $749K in Q2 2015.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on Stifel Financial's 13F filing for Q4 2020, filed 12 Feb 2021.